ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAB1. A total of 1 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $50,155,000 | +50.7% | 16,500,000 | -13.2% | 1.42% | +45.7% |
| Q1 2019 | $33,290,000 | +45.7% | 19,000,000 | 0.0% | 0.97% | +6.0% |
| Q4 2018 | $22,845,000 | -3.7% | 19,000,000 | 0.0% | 0.92% | +25.9% |
| Q3 2018 | $23,717,000 | -7.1% | 19,000,000 | 0.0% | 0.73% | -15.8% |
| Q2 2018 | $25,524,000 | +1.3% | 19,000,000 | 0.0% | 0.87% | -10.9% |
| Q1 2018 | $25,196,000 | +16.8% | 19,000,000 | 0.0% | 0.97% | +3.7% |
| Q4 2017 | $21,578,000 | – | 19,000,000 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 14,100,000 | $15,994,000 | 1.22% |
| Redmile Group, LLC | 19,000,000 | $21,578,000 | 0.94% |
| Verition Fund Management LLC | 6,000,000 | $6,754,000 | 0.62% |
| Graham Capital Management, L.P. | 10,000,000 | $11,326,000 | 0.30% |
| LINDEN ADVISORS LP | 7,035,000 | $7,957,000 | 0.24% |
| CSS LLC/IL | 3,405,000 | $3,846,000 | 0.19% |
| OAKTREE CAPITAL MANAGEMENT LP | 8,000,000 | $9,005,000 | 0.14% |
| WOLVERINE ASSET MANAGEMENT LLC | 8,715,000 | $9,838,000 | 0.10% |
| Allianz Asset Management GmbH | 21,830,000 | $24,057,000 | 0.02% |
| Citadel Advisors | 27,570,000 | $31,249,000 | 0.02% |